Top 10 Medical Device Angel Investors in Singapore
A list of 10 angel investors that invest in Medical device startups based in Singapore. We rank investors based on the number of investments they made in Medical device companies from Singapore. We update this investor list every month.Top 10 Medical Device Angel Investors in Singapore
Investor | Medical Device Singapore investments |
---|---|
Feng Hu | 1 |
Jack Wang | 1 |
Paul Buchheit | 1 |
Matt Cutts | 1 |
Frederik Vandermarlie | 1 |
Benjamin Boyer | 1 |
Binny Bansal | 1 |
Eric Urhane | 1 |
Avi Reichental | 1 |
Johannes Hille | 1 |
Feng Hu
Show more
Investment focus
- Communities, Mobile Apps, Health Care
- Seed, Pre-Seed, Convertible Note
- United States, India, Singapore
Portfolio highlights
- Credy — Credy provides instant online loan at low interest rate. Apply now for personal loan, education loan, medical loan, credit refinancing or other loans.
- DIVE - Dating With Games — DIVE-Dating With Gaming is a trendy dating and gaming app. It offers super interesting roleplay games that break the ice and that lead to deeper and more fun experiences between matches.
- Audetemi Inc. — Audetemi makes it easy for enterprises to enable their business on mobile, and create a superior, and engaging customer experience. Audetemi One platform allows businesses to effectively engage their customers by seamlessly integrating traditional customer engagement platforms onto their smartphones.
Jack Wang
Show more
Investment focus
- Fertility, Biotechnology, Medical Device
- Seed
- Singapore
Portfolio highlights
- Hannah Life Technologies — We make Earth's best products and services for couples in their parenthood journey.
Paul Buchheit co-founded social network aggregator FriendFeed, along with three other former Google employees. He is also an investor in FriendFeed and participated in a $5 million Series A round in February 2008.He was the 23rd employee at Google, where he created Gmail and implemented many of its innovative features. He developed the originalprototype of Google AdSense, and was responsible for Google's famous "Don't be evil" motto in a meeting.
Show more
Investment focus
- Software, Health Care, E-Commerce
- Seed, Series A, Angel
- United States, Canada, India
Portfolio highlights
- SiPhox Health — SiPhox offers a handheld testing device with RNA/DNA and protein testing for point-of-care and At-Home solutions. The company's kit is made by multiplexing RNA, antibody, and antigen tests on a single silicon photonic chip which is amplified by plasmon resonance and silicon photonic resonator readout, enabling users to undertake tests fordisease safely and in a disposable point-of-care and at-home manner.SiPhox was founded in 2020 and is based in Cambridge, Massachusetts, USA.
- Character.ai — Meet AIs that feel alive. Chat with anyone, anywhere, anytime. Experience the power of super-intelligent chat bots that hear you, understand you, and remember you.
- Perplexity AI — Perplexity is a search engine platform that uses artificial intelligence to provide large language models and search engines. The company's platform enables the development of beneficial artificial general intelligence, as well as an open-source environment that is accessible to the public, allowing clients to develop skills and knowledge inartificial intelligence.
Matt Cutts joined Google as a Software Engineer in January 2000. Before Google, he was working on his Ph.D. in computer graphics at the University of North Carolina at Chapel Hill. He has an M.S. from UNC-Chapel Hill, and B.S. degrees in both mathematics and computer science from the University of Kentucky.Matt wrote SafeSearch, which isGoogle's family filter. In addition to his experience at Google, Matt held a top-secret clearance while working for the Department of Defense, and he's also worked at a game engine company. He claims that Google is the most fun by far.Matt talks about webmaster-related issues on his
Show more
Investment focus
- SaaS, Health Care, Software
- Seed, Angel, Series A
- United States, Canada, Mexico
Portfolio highlights
- Unima — Unima is decentralizing rapid testing across industries by taking diagnostics out of the lab to the place these are needed the most to secure a timely diagnostic for everyone, anywhere.Unima is solving is the centralization of lab testing, which limits the access to a timely diagnostic for billions. Current technology for diagnostics is veryprecise and can detect almost any disease known, but the problem is these require labs with expensive equipment and specialized technicians making lab testing impossible to scale up to provide universal and timely access to diagnostics.To solve this problem Unima developed Find, a rapid testing technology platform for real time diagnostics which allows anyone to diagnose a disease directly where it is needed, without using lab equipment, with results in 15 minutes or less and at a very low cost. With Find anyone can have access to a timely diagnostic even in the most remote areas of the world.The Find platform uses shark antibodies modified with genetic engineering to detect disease biomarkers in blood, saliva, urine or water samples. These shark antibodies are used in microfluidic cards and generate a visual reactions when in contact with specific biomarkers of the disease to be tested. Then to evaluate the result of the test, a picture of the testing card is taken with the proprietary Xplora smartphone app which runs image analysis process and neural network algorithms to generate an inmediate result. Then this result,along with contextual information like geolocation, date and time, is sent to a cloud server where it can be used for real time disease tracking.
- X-ZELL — Early, pain-free cancer cell detection
- Meter Feeder — Easily pay for parking through MeterFeeder
Frederik Vandermarlie
Show more
Investment focus
- Medical, Legal Tech, Health Care
- Seed
- Belgium, Singapore
Ben Boyer is a Managing Director of Tenaya Capital, and he has been a member of the Tenaya investment team since 2000.Previously, Ben was a member of Lehman Brothers' Technology Investment Banking group, where he was responsible for corporate finance and strategic advisory assignments.Ben holds an M.B.A. from Stanford Graduate Schoolof Business and a B.S. in human and organizational development from Vanderbilt University.
Show more
Investment focus
- Software, E-Commerce, Internet
- Series C, Seed, Series B
- United States, China, Singapore
Portfolio highlights
- Kangaroo — No hidden upfront costs or astronomical monthly monitoring fees. Our plans are contract-free, flexible and affordable. We even help you earn cash back on your insurance policy! Our sensors are batteries-included, peel-and-stick, app-controlled easy. Choose a free plan or professionally monitored plan for only $99/yr.
- People.ai — Uncover the Fastest Path to Revenue
- Triparound — Get access to the ultimate travel planning platform for maximized ancillary revenue and operational efficiency!
Binny Bansal is an Indian software engineer and Internet entrepreneur. In 2007 he co-founded the e-commerce platform Flipkart with Sachin Bansal (not related) and was serving as the Chief Operating Officer until 11 January 2016 and was promoted to Chief Executive Officer. In January 2017 he was promoted to Group CEO of Flipkart. Binny is fromChandigarh and graduated from the Indian Institute of Technology Delhi with a degree in Computer Science and Engineering.
Show more
Investment focus
- Software, Internet, E-Commerce
- Seed, Series A, Funding Round
- India, United States, Singapore
Portfolio highlights
- OppDoor — Launch your Amazon Brand into Thriving International Markets. OppDoor is a Growth Partner for Amazon Brands.
- Leela Life — Timeless Indian wellbeing secrets for peaceful and joyful living
- Alltius Inc. — Alltius is an AI-driven platform for conversational assistance in software products primarily to help and guide users in their product journeys.
Eric Urhane
Show more
Investment focus
- Software, Health Care, Biotechnology
- Seed, Angel
- United States, Mexico, Singapore
Portfolio highlights
- Unima — Unima is decentralizing rapid testing across industries by taking diagnostics out of the lab to the place these are needed the most to secure a timely diagnostic for everyone, anywhere.Unima is solving is the centralization of lab testing, which limits the access to a timely diagnostic for billions. Current technology for diagnostics is veryprecise and can detect almost any disease known, but the problem is these require labs with expensive equipment and specialized technicians making lab testing impossible to scale up to provide universal and timely access to diagnostics.To solve this problem Unima developed Find, a rapid testing technology platform for real time diagnostics which allows anyone to diagnose a disease directly where it is needed, without using lab equipment, with results in 15 minutes or less and at a very low cost. With Find anyone can have access to a timely diagnostic even in the most remote areas of the world.The Find platform uses shark antibodies modified with genetic engineering to detect disease biomarkers in blood, saliva, urine or water samples. These shark antibodies are used in microfluidic cards and generate a visual reactions when in contact with specific biomarkers of the disease to be tested. Then to evaluate the result of the test, a picture of the testing card is taken with the proprietary Xplora smartphone app which runs image analysis process and neural network algorithms to generate an inmediate result. Then this result,along with contextual information like geolocation, date and time, is sent to a cloud server where it can be used for real time disease tracking.
- X-ZELL — Early, pain-free cancer cell detection
- Chirply — Chirply is a platform for crowd-sourcing & crowd-curating design. Chirply's mission is to build engagement, stickiness, and virality through crowd-sourcing design. Initially the company focused on the launch of a marketplace for crowd-sourced design for paper goods - an industry that hasn't been disrupted since the advent of theprinting press. Chirply then launched a B2B platform for crowd-sourced design for brands to help engage users and use design to make daily products inspiring.
Avi Reichental is the current Co-Founder & Chairman of ParaMatters. He previously worked at Singularity University as a Core Faculty.
Show more
Investment focus
- Health Care, 3D Technology, Internet of Things
- Seed, Angel
- United States, Israel, Singapore
Portfolio highlights
- NXT Factory — Development a groundbreaking beam delivery system, that converts a single laser into several million microlasers, without power degradation.
- ParaMatters — Paramatters is a team of world-class experts in topology optimization, computational mechanics, CAD and artificial intelligence.
- Centaur Analytics, Inc. — Centaur Analytics is a industrial data and IoT analytics platform for post-harvest quality monitoring.Centaur Analytics use data science and sensors to monitor and predict product quality and safety for grains, like malting barley, wheat, and other commodities.
Johannes Hille
Show more
Investment focus
- Medical, Health Care, Biotechnology
- Seed
- Singapore
Portfolio highlights
- X-ZELL — Early, pain-free cancer cell detection
Investors by industry
Health Care
Biotech
Community
Marketplace
FinTech
Impact
Proptech
Media (entertainment)
EdTech
Consumer
Climate
Energy
Hardware
Gaming
Artificial intelligence
Sustainability
Agriculture (agtech)
Venture Capital
Restaurants
Publishing
Beauty
Oil and Gas
Web3
Video Games
Food and Beverage
Clean Energy
Real Estate
Infrastructure
Big Data
Organic Food
Medical
Email
Wellness
Social Media
Music
Photography
Franchise
Celebrity
Android
Internet
Legal
Google
eSports
Construction
Local
Mobile
Enterprise Software
Sports
Social Network
Manufacturing
Digital Media
Facebook
Art
Social Impact
Fashion
Recruiting
Platforms
Travel
Fitness
Mobile Advertising
Education
Cannabis
B2B
Biotechnology
Hospitality
Renewable Energy
Payments
Automotive
Crowdfunding
Wine And Spirits
Financial Services
Medical Device
Sporting Goods
Social
Finance
CleanTech
Retail
Transportation
Mobile Apps
Enterprise
InsurTech
LGBT
Film
Life Science
Theatre
Non Profit
Cryptocurrency
SaaS
Software
Blockchain
Investors by country
Canada
United Kingdom
Ireland
Germany
South Korea
Australia
United States
India
New Zealand
Oceania
Armenia
China
Europe
Indonesia
LATAM
Middle East
Spain
Asia
Japan
South Africa
Qatar
Vietnam
Saudi Arabia
Singapore
Sri Lanka
Brazil
Czech Republic
Bahrain
Belize
Bermuda
Costa Rica
Belarus
Bulgaria
Denmark
Algeria
Georgia
Gibraltar
Cameroon
Chile
Finland
Estonia
Faroe Islands
Greece
Ethiopia
Ghana
Hungary
Croatia
Egypt
Belgium
Barbados
Ecuador
France
Hong Kong
Kuwait
Israel
Jersey
Kazakhstan
Nicaragua
Philippines
Italy
Mali
Lithuania
Cambodia
Liechtenstein
Kenya
Liberia
Lebanon
Mauritius
Morocco
Malaysia
Norway
Peru
Myanmar
Cayman Islands
Panama
Malta
Mexico
Seychelles
Slovenia
Russian Federation
Rwanda
Serbia
Uzbekistan
Togo
Taiwan
Ukraine
Sierra Leone
Turkey
Tunisia
Thailand
Tajikistan
Poland
Uganda
Zimbabwe
Tanzania
San Marino
Uruguay
Venezuela
Zambia
Senegal
Puerto Rico
Portugal
Sweden
El Salvador
Nigeria
Bahamas
Azerbaijan
Iraq
Iceland
Namibia
United Arab Emirates
Honduras
Isle of Man
Bolivia
Luxembourg
Pakistan
Albania
Argentina
Bangladesh
Grenada
Jordan
Romania
Austria
Africa
Cyprus
Latvia
Oman
Colombia
Switzerland
Guatemala
Marshall Islands
Angel Investors in Singapore by industry
Crowdfunding
Financial Services
Big Data
Cryptocurrency
Finance
Education
Payments
Food and Beverage
Restaurants
Organic Food
Video Games
Wellness
Medical
Medical Device
Sustainability
Internet
Social Media
Manufacturing
Digital Media
Blockchain
Recruiting
Android
Mobile
Construction
Legal
Software
Enterprise Software
eSports
Hospitality
Travel
Platforms
InsurTech
FinTech
Consumer
Health Care
Biotech
Climate
EdTech
Energy
SaaS
Marketplace
Hardware
Agriculture (agtech)
Community
Retail
Gaming
Media (entertainment)
Social
Fashion
Web3
B2B
Publishing
Proptech
Sports
Transportation
Real Estate
Mobile Apps
Beauty
Fitness
Biotechnology
Social Network
Artificial intelligence
Enterprise
Impact